Your browser doesn't support javascript.
loading
Assessing bidirectional associations between cognitive impairment and late age-related macular degeneration in the Age-Related Eye Disease Study 2.
Le, Jimmy T; Agrón, Elvira; Keenan, Tiarnan D L; Clemons, Traci E; Brenowitz, Willa D; Yaffe, Kristine; Chew, Emily Y.
Affiliation
  • Le JT; Division of Epidemiology and Clinical Applications & Division of Extramural Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Agrón E; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Keenan TDL; Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Clemons TE; The Emmes Company, LLC, Rockville, Maryland, USA.
  • Brenowitz WD; Departments of Psychiatry and Behavioral Science, Neurology, and Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, USA.
  • Yaffe K; Department of Neurology, University of California San Francisco, San Francisco, San Francisco, California, USA.
  • Chew EY; Departments of Psychiatry and Behavioral Science, Neurology, and Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Alzheimers Dement ; 18(7): 1296-1305, 2022 07.
Article in En | MEDLINE | ID: mdl-34758100
ABSTRACT

INTRODUCTION:

We aimed to investigate bidirectional associations between cognitive impairment and late age-related macular degeneration (AMD).

METHODS:

Participants in the Age-Related Eye Disease Study 2 (AREDS2) received annual eye examinations and cognitive function testing (e.g., Modified Telephone Interview for Cognitive Status [TICS-M]). We examined bidirectional associations between cognitive impairment (e.g., a TICS-M score < 30) and late AMD at 5 and 10 years.

RESULTS:

Five thousand one hundred eighty-nine eyes (3157 participants; mean age 72.7 years) were analyzed and followed for a median of 10.4 years. Eyes of participants with cognitive impairment at baseline were more likely to progress to late AMD at 5 years (hazard ratio [HR], 1.24; 95% confidence interval [CI], 1.08-1.43) and 10 years (HR, 1.20; 95% CI, 1.05-1.37) than eyes of participants without cognitive impairment. Worse baseline AMD severity was not associated with developing cognitive impairment.

DISCUSSION:

Cognitive impairment is associated with late AMD progression in AREDS2. Our finding highlights the importance of eyecare for people with cognitive impairment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognitive Dysfunction / Macular Degeneration Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Alzheimers Dement Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognitive Dysfunction / Macular Degeneration Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: Alzheimers Dement Year: 2022 Document type: Article Affiliation country: